title: Update on primary PCI for patients with STEMI.
abstract: Primary PCI is the dominant reperfusion strategy for patients with ST-elevation myocardial infarction and continues to evolve. The purpose of this review is to summarize recent reports that focused on the relationship of door-to-balloon time with mortality, radial versus femoral artery access, aspiration thrombectomy, culprit versus multivessel primary PCI, drug-eluting stents, and anticoagulation and antiplatelet therapies.
authors.affiliation: Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan Medical Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5869.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Thomas
authors.affiliation: Division of Cardiovascular Diseases, Department of Internal Medicine, University of Michigan Medical Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5869. Electronic address: ebates@umich.edu.
authors.forename: Eric R
authors.initials: ER
authors.lastname: Bates
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D004334:Drug Administration Schedule; D054855:Drug-Eluting Stents; D005263:Femoral Artery; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods / Q000401:mortality; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D011677:Punctures; D017534:Radial Artery; D012307:Risk Factors; D000072657:ST Elevation Myocardial Infarction / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D017131:Thrombectomy; D013997:Time Factors; D061665:Time-to-Treatment; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
keywords: Coronary artery disease; Myocardial infarction; Percutaneous coronary intervention